Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbott laboratories - ferrous sulfate, folic acid - tablet - 325, 350 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: n/a - ferrous sulfate , folic acid (vitamin b9) - film-coated tablet - 187.50 mg (equivalent to 60 mg of elemental iron)/ 400 mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; distributor: n/a - multivitamins , minerals (vet.) - chewable tablet - formulation: each chewable tablet contains: retinyl acetate (vitamin a)5,000 iu colecalciferol (vitamin d.) 400 iu riboflavin (vitamin bs) 3 mg dl-alpha tocophreyl acetate (vitamin e) 25 iu thiamine hydrochloride (vitamin b1)1.5 mg folic acid (vitamin b9) 1 mg ascorbic acid (vitamin c) 50 mg cyanocobalamin (vitamin b12)2 μg niacinamide (vitamin b1) 15 mg ferrous sulfate 30 mg pyridoxine hydrochloride (vitamin b6) 5 mg calcium pantothenate (vitamin b12) 5 mg magnesium sulfate heptahydrate3 mg potassium iodide 150 μg

Australia - English - Department of Health (Therapeutic Goods Administration)

carotino (australia) pty ltd - folic acid, quantity: 0.3 mg; ferrous sulfate, quantity: 270 mg (equivalent: iron, qty 87.4 mg) - capsule, modified release - excipient ingredients: sunset yellow fcf; glyceryl monostearate; maize starch; quinoline yellow; purified talc; calcium sulfate dihydrate; hydrochloric acid; erythrosine; sucrose; gelatin; povidone; white beeswax; titanium dioxide; brilliant blue fcf - for the prevention and treatment of iron and folate deficiency,supplies iron to the body which may help in the production of energy,can help relieve fatigue associated with iron deficiency

Canada - English - Health Canada

pharmavite llc - pyridoxine hydrochloride; folic acid; vitamin b12; iron (ferrous fumarate); vitamin a acetate; ascorbic acid (ascorbic acid, niacinamide ascorbate); dl-alpha tocopheryl acetate; vitamin d; thiamine mononitrate; vitamin b2; nicotinamide - tablet - 1.05mg; .3mg; 4.5mcg; 4mg; 2500unit; 60mg; 15unit; 400unit; 1.05mg; 1.2mg; 13.5mg - pyridoxine hydrochloride 1.05mg; folic acid .3mg; vitamin b12 4.5mcg; iron (ferrous fumarate) 4mg; vitamin a acetate 2500unit; ascorbic acid (ascorbic acid, niacinamide ascorbate) 60mg; dl-alpha tocopheryl acetate 15unit; vitamin d 400unit; thiamine mononitrate 1.05mg; vitamin b2 1.2mg; nicotinamide 13.5mg - vitamins & minerals

United States - English - NLM (National Library of Medicine)

meda pharmaceuticals - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - folic acid 1 mg

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 151 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions). soybean oil, lecithin, di calcium phosphate anhydrous, beeswax yellow, hydrogenated soybean oil.

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions).

United States - English - NLM (National Library of Medicine)

trigen laboratories, llc - levomefolic acid (unii: 8s95dh25xc) (levomefolic acid - unii:8s95dh25xc), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j9 - levomefolic acid 500 ug - tl folate is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

nationwide laboratories, llc - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), beta carotene (unii: 01yae03m7j) (beta carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), nia - folic acid 1 mg - prenatal 19 chewable tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in postnatal period for both lactating and non-lactating mothers. prenatal 19 chewable tablets are also useful in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.